Clinical trial of effects of alogliptin bensoate on endothelial function in type II diabetes mellitus

Clinical trial of effects of alogliptin bensoate on endothelial function in type II diabetes mellitus - alogliptin benzoate study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007722

Enrollment

100

Registered

2012-04-11

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II diabetes mellitus

Interventions

Alogliptin treatment Untreated (control)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type II diabetes mellitus

Exclusion criteria

Exclusion criteria: Patients with cancer Patients with stroke and/or myocardial infarction within 12 weeks of the prior to study Patients with heart failure who have NYHA 4

Design outcomes

Primary

Measure	Time frame
endothelial function, Rho kinase actvity	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026